Literature DB >> 19587019

A critical role for REV1 in regulating the induction of C:G transitions and A:T mutations during Ig gene hypermutation.

Keiji Masuda1, Rika Ouchida, Yingqian Li, Xiang Gao, Hiromi Mori, Ji-Yang Wang.   

Abstract

REV1 is a deoxycytidyl transferase that catalyzes the incorporation of deoxycytidines opposite deoxyguanines and abasic sites. To explore the role of its catalytic activity in Ig gene hypermutation in mammalian cells, we have generated mice expressing a catalytically inactive REV1 (REV1AA). REV1AA mice developed normally and were fertile on a pure C57BL/6 genetic background. B and T cell development and maturation were not affected, and REV1AA B cells underwent normal activation and class switch recombination. Analysis of Ig gene hypermutation in REV1AA mice revealed a great decrease of C to G and G to C transversions, consistent with the disruption of its deoxycytidyl transferase activity. Intriguingly, REV1AA mice also exhibited a significant reduction of C to T and G to A transitions. Moreover, each type of nucleotide substitutions at A:T base pairs was uniformly reduced in REV1AA mice, a phenotype similar to that observed in mice haploinsufficient for Polh. These results reveal an unexpected role for REV1 in the generation of C:G transitions and A:T mutations and suggest that REV1 is involved in multiple mutagenic pathways through functional interaction with other polymerases during the hypermutation process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587019     DOI: 10.4049/jimmunol.0901240

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Immunoglobulin class-switch DNA recombination: induction, targeting and beyond.

Authors:  Zhenming Xu; Hong Zan; Egest J Pone; Thach Mai; Paolo Casali
Journal:  Nat Rev Immunol       Date:  2012-06-25       Impact factor: 53.106

2.  Effects of Twelve Germline Missense Variations on DNA Lesion and G-Quadruplex Bypass Activities of Human DNA Polymerase REV1.

Authors:  Mina Yeom; In-Hyeok Kim; Jae-Kwon Kim; KyeongJin Kang; Robert L Eoff; F Peter Guengerich; Jeong-Yun Choi
Journal:  Chem Res Toxicol       Date:  2016-03-04       Impact factor: 3.739

Review 3.  Translesion DNA synthesis and mutagenesis in eukaryotes.

Authors:  Julian E Sale
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

4.  A high-resolution landscape of mutations in the BCL6 super-enhancer in normal human B cells.

Authors:  Jiang-Cheng Shen; Ashwini S Kamath-Loeb; Brendan F Kohrn; Keith R Loeb; Bradley D Preston; Lawrence A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-20       Impact factor: 11.205

Review 5.  The Rev1-Polζ translesion synthesis mutasome: Structure, interactions and inhibition.

Authors:  Alessandro A Rizzo; Dmitry M Korzhnev
Journal:  Enzymes       Date:  2019-08-09

6.  Rev1 recruits ung to switch regions and enhances du glycosylation for immunoglobulin class switch DNA recombination.

Authors:  Hong Zan; Clayton A White; Lisa M Thomas; Thach Mai; Guideng Li; Zhenming Xu; Jinsong Zhang; Paolo Casali
Journal:  Cell Rep       Date:  2012-11-08       Impact factor: 9.423

Review 7.  Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases.

Authors:  Kimberly J Zanotti; Patricia J Gearhart
Journal:  DNA Repair (Amst)       Date:  2015-12-02

8.  Defining the immunological phenotype of Fc receptor-like B (FCRLB) deficient mice: Confounding role of the inhibitory FcγRIIb.

Authors:  Keiji Masuda; Hiromi Mori; Osamu Ohara; Manabu Nakayama; Ji-Yang Wang; Peter D Burrows
Journal:  Cell Immunol       Date:  2010       Impact factor: 4.868

Review 9.  DNA polymerases and cancer.

Authors:  Sabine S Lange; Kei-ichi Takata; Richard D Wood
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 10.  Opinion: uracil DNA glycosylase (UNG) plays distinct and non-canonical roles in somatic hypermutation and class switch recombination.

Authors:  Ashraf S Yousif; Andre Stanlie; Nasim A Begum; Tasuku Honjo
Journal:  Int Immunol       Date:  2014-07-03       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.